Exagen Inc (NAS:XGN)
$ 2.75 -0.04 (-1.43%) Market Cap: 47.81 Mil Enterprise Value: 47.91 Mil PE Ratio: 0 PB Ratio: 2.72 GF Score: 70/100

Q4 2019 Exagen Inc Earnings Call Transcript

Mar 25, 2020 / 08:30PM GMT
Release Date Price: $12.7 (-5.51%)
Operator

Good afternoon. Welcome to Exagen Inc's. Fourth Quarter and Full Year 2019 Results Conference Call. As a reminder, today's call is being recorded.

We will begin today's call with opening remarks and introductions, followed by a question-and-answer session. I would like to turn the call over to Mr. Mark Hazeltine, Senior Vice President of Finance and Corporate Development. Please go ahead, sir.

Mark Hazeltine
Exagen Inc. - SVP of Finance & Corporate Development

Good afternoon, and thank you for joining us today. Earlier today, Exagen Inc. released financial results for the quarter and year ended December 31, 2019. The release is currently available on the company's website at www.exigen.com. Ron Rocca, President and Chief Executive Officer; and Kamal Adawi, Chief Financial Officer, will host this afternoon's call.

Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements within the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot